A quantitative analysis of MRI images using commercial software for the assessment of radiotherapy-induced anatomical changes of parotid glands Gerlinde Logghe Supervisors: Prof. Dirk Verellen, Prof. Giovanna Rizzo (University of Milano-Bicocca, Italy) Counsellor: Prof. Claudio Fiorino (Servizio Fisica Sanitaria - Ospedale San Raffaele IRCCS) Master's dissertation submitted in order to obtain the academic degree of Master of Science in Biomedical Engineering Faculty of Engineering and Architecture Academic year 2014-2015 Permission for usage “The author(s) gives (give) permission to make this master dissertation available for consultation and to copy parts of this master dissertation for personal use. In the case of any other use, the copyright terms have to be respected, in particular with regard to the obligation to state expressly the source when quoting results from this master dissertation” Gerlinde Logghe 21/05/2015 i Preface Writing this thesis is the final chapter of my life as a student and I would like to thank some people that have made this experience possible for me. My parents, who gave me the opportunity to study for all these years and who supported me in all my decisions. My brother Barteld, who has always believed in me. Professor Verellen, who has helped me finding a thesis subject abroad and who agreed to be my supervisor. Claudio Fiorino and dr. Giovanna Rizzo for guiding and helping me to write this thesis and for welcoming me in Milan. Maria-‐Luisa Belli and Sara Broggi for helping me with the project and answering my many questions. My colleagues in the San Raffaele Hospital and LITA. You made my stay in Milan unforgettable. ii Abstract A quantitative analysis of MRI images using commercial software for the assessment of radiotherapy-‐induced anatomical changes of parotid glands Gerlinde Logghe Supervisors: Prof. Dirk Verellen, Prof. Giovanna Rizzo (University of Milano-‐Bicocca, Italy) Counsellors: Prof. Claudio Fiorino (Servizio Fisica Sanitaria – Ospedale San Raffaele IRCCS) Master's dissertation submitted in order to obtain the academic degree of Master of Science in Biomedical Engineering Faculty of Engineering and Architecture, Academic year 2014 -‐ 1015 Summary Radiotherapy is one of the main therapies to treat head and neck cancer (HNC). However, one of the consequences of radiation therapy is the radiation-‐induced damage to normal tissue and cells. In HNC patients, one of the main side effects is xerostomia, which is the result of a change of saliva composition or reduced saliva flow. Image analysis, and in particular deformable image registration (DIR), is used to investigate parotid shrinkage, which can lead to xerostomia, and can be used to investigate certain clinical and dosimetric parameters that could predict this shrinkage. In this Masters dissertation, MIM software, will be used for MRI/MRI monomodality deformable registration and contour propagation. After the accuracy of the deformable registration and contour propagation is validated (correct for all but one parotid gland), MIM software is used for a clinical application: the determination of radiation-‐induced parotid shrinkage and correlation with clinical and dosimetric parameters. Significant changes in parotid gland volume in the acute (2-‐3 months) and late phase (6-‐18 months), compared with the pre-‐RT scan are noticed and initial volume seems to be correlated with volume loss in the acute phase. Also 2 subpopulations were found to be present, which could be explained by a difference in mean planned dose to the parotid. Mean planned dose seems to be correlated with volume loss in the late phase, especially for the high-‐dose group. The contour-‐propagation tool included in MIM software reduces the contouring time with 50 % iii A quantitative analysis of MRI images using commercial software for the assessment of radiotherapy-induced anatomical changes of parotid glands Gerlinde Logghe Supervisor(s): Giovanna Rizzo, Claudio Fiorino the region of the oropharynx, 5 in the nasopharynx. In 7 of Abstract In this research, the use of MIM software for these patients, the tumour was located bilaterally, while in 5 MRI/MRI deformable registration and contour propagation is of them the tumour was located at the right side, and in other investigated and validated. As an application of MIM software, 2 patients at the left side. There were 8 males and 6 female the predictive value of some clinical and anatomical parameters patients. The PTV1 – dose ranged from 61,5 Gy to 67 Gy with for parotid shrinkage is investigated. 2,05 to 2,3 Gy per fraction (30 fractions) and the PTV2- from Keywords MIM software, MRI, DIR, parotid gland shrinkage 54 Gy to 56 Gy with 1,8 to 1,9 Gy per fraction (30 fractions). The mean dose to the parotid glands was 32,6 Gy and ranged from 21,8 Gy to 51,6 Gy. I. INTRODUCTION The MRI scans are performed with a THRIVE sequence Cancer of the head and neck region (HNC) is the seventh using a Philips machine (Achieva 1.5 and Philips Interna for leading cancer worldwide. Radiotherapy is one of the main patient 5). This is T1-weighted high-resolution isotropic therapies to treat HNC; Ionizing radiation is used to introduce volume examination sequence (THRIVE) with 3D ultra-fast damage in the DNA, which will lead to cell death and spoiled gradient, useful for soft-tissue imaging as it provides impaired cell division. However, one of the consequences of more detailed anatomical information while retaining a good radiation therapy is the radiation-induced damage to normal spatial resolution and having an acceptable acquisition time. tissue. In HNC patients, one of the main side effects is dryness of the mouth, also known as xerostomia, which is the result of B. MIM Software a change of saliva composition or reduced saliva flow. The Version 6.3 of MIM software (Cleveland, Ohio) is used in parotid glands are the mayor contributor to the saliva this thesis project. MIM offers a great flexibility and production, and shrinkage has been suggested to be an efficiency for its users and its design philosophy was based on indicator of xerostomia. Image analysis, and in particular offering the user an intuitive and friendly interface. However, deformable image registration (DIR), is used to investigate details regarding the implementation of the algorithms behind parotid shrinkage and certain clinical and dosimetric these tools are not available to users. parameters that could predict this shrinkage in the parotid Rigid and deformable registration in combination with glands. contour propagation, are the main tools used in this thesis project. Contour propagation is linked to registration by using MIM software has been used extensively for CT/CT DIR, the registration field to propagate the contours from one image but there is not much information available on MRI/MRI DIR. to the other. DICE Coefficients and Hausdorff distance values Therefore the aim of this thesis is also to find a protocol in will be used to evaluate the propagation/registration. Several MIM software for MRI/MRI DIR of HNC patients that will settings are possible for registration (rigid and deformable), give adequate and acceptable results in terms of accuracy. and the most optimal setting will be investigated and In a second part, selected parameters that could be validated. For this step a subset of 10 patients is used. correlated with parotid gland shrinkage are investigated by the use of MIM software. C. Statistical Tests SPSS (IBM ® SPSS ® Statistics) Version 21 is used for II. EXPERIMENTAL RESEARCH statistical analysis. The Wilcoxon signed-rank test is used for the comparison of means in repeated measurements (pre-RT A. Patient Data-set vs. acute/late phase scan). The independent-Samples Mann- Whitney U test is used for the comparison of means in two 14 patients were selected from a database containing HNC patients. These 14 patients all had a pre-treatment MRI scan, independent samples. an acute phase MRI scan (2-3 months after treatments) and a late phase MRI scan (6-18 months later). The ages of the patients ranged from 33 to 78 years with a median value of 55,4 years. 9 of them had a tumour located in III. RESULTS smaller group (group 2), consisting of only 6 parotid glands, shows a decline in the acute phase (from ± 23 ml to ± 20ml), followed by a further decline in the late phase (to ±16,5 ml). A. Parameter settings and validation in MIM Software The volume changes in the second group are smaller when The combination of a rigid registration with a region that compared to the first group as well as the pre-RT volume. includes the parotid glands (‘Box Based Assisted Alignment’) The correlation between volume loss and certain parameters together with a deformable registration that focuses on the (initial volume, mean planned dose, %overlap between PTV whole image, gave the best results (maximum DICE and parotid gland, age, and gender) was investigated, see coefficient and minimum Hausdorff distance values). Table I. However, the differences with the other registration approaches are small and no statistical significance is Table I Correlation between certain parameters and volume loss of determined. parotid glands in acute an late phase It was found that a deformable smoothness factor (DSF) of Total Group 1 Group 2 0,5 is the optimal setting when working with MRI/MRI image registration. However, in the cases where the images are Para- Acute Late Acute Late Acute Late subjected to some degree of artefacts and/or noise or where meters: the volumes differ too much between the 2 images, it is better to use a deformable smoothness factor of 2. When these 2 Initial 0,669 deformable smoothness factors are being considered, it can be volume ** 0,267 0,711 concluded that all patients (with the exception of one parotid in patient 7) have a median error (Hausdorff distance median) that falls within the voxel size, see Figure I This means that Mean the registration protocol can be used for further MRI/MRI planned -0,054 0,365 0,241 0,249 -0,257 0,429 dose registrations. % overlap -0,031 0,112 0,139 0,132 -0,329 0,188 with PTV Age 0,034- 0,132 There is a difference in volume between man and female patients. Gender However, this does not translate into a significant difference in relative volume loss between man and female. Figure I Validation results C. Reduction in contouring time B. Clinical and dosimetric parameters that can predict From the volume extraction experiment, it was concluded parotid shrinkage that the deformable registration process/contour propagation tool in MIM is not sufficient enough to produce propagated It was found that there are significant changes in parotid contours that don’t need manual adjustment. However, it was gland volume when going from the pre-treatment to the acute noticed that when the propagation tool was used, the (2-3 months) and late phase (6-18 months). Two contouring phase goes much faster. In order to assess the gain subpopulations were found to be present, see Figure II. in time due to the combination of propagation+manual adjustment vs. manual contouring, the last 4 patients of the volume extraction protocol were used, together with 5 other patients that only had an acute or late phase scan (and thus were not included in the volume extraction experiment). The average time needed for manually contouring both parotid glands is about 62,11 minutes, while when the contour propagation tool is used there is a reduction to 31,63 min in acute phase and 31,40 min in late phase, which equals a reduction of about 50%, see table Table II Table II Time reduction for contouring Figure II Volume changes for 2 subpopulations Contouring time (in minutes) Acute Scan Late Scan The large majority of parotids (n=22 parotid glands, group Pre- (propagated (propagated treatment 1) are characterized by an initial decline of volume in the contours + contours + scan acute phase (from ± 28 ml to ±20 ml), followed by a plateau adjustment) adjustment) 1 1 73 40 29 or even an increase in the late phase (from ±20 ml to ± 23,5 12 53 25 27 ml). However, the original volume is never reached again. A 13 67 35 35 V. CONCLUSION 14 68 34 32 15 54 30 / It was found that MIM software is able perform a MRI/MRI 16 57 25 / deformable registration and contour propagation with enough 17 61 / 34 accuracy (less than max. voxel error). However, the 18 61 30 / performance of MIM software should be compared with open- 19 65 34 / source software programs that already have been used to Average 62,11 31,63 31,40 Average/gland 31,06 15,81 15,70 explore and optimize MRI/MRI registration, such as Elastix. %reduction 49,08 49,45 As these programs are open-source software systems and the user itself creates the algorithm, it is expected that these results will be more accurate but will be more time- IV. DISCUSSION consuming. It was shown in this thesis, that the DIR tool of MIM has enough accuracy to be used, so it has to be A. Parameter settings and validation in MIM Software investigated whether a higher accuracy will result in noticeably better clinical and practical outcome. For the analysis of MRI images, it was found that the best Concerning the found correlations between volume loss and deformable registration is obtained when using ‘Box Based certain clinical and dosimetric parameters, it needs to be Assisted Alignment’ focused on the parotid glands, a investigated if the conclusions from this research still hold in deformable registration without focusing on a specific ROI a larger population. If so, it should also be investigated and a deformable smoothness of 0,5 and 2. whether or not a linear regression model can be build with The observations about the DSF were later confirmed these parameters. This model could than be used as a during a webinar organized by Jonathan W. Piper (MIM predictive model for parotid shrinkage. software) about ‘Deformable Image Registration and Quality Also data about toxicity and xerostomia in the patients are Assurance’ using MIM software [1]. necessary to draw any valid conclusion about radiation- By comparing the Hausdorff distances between the manual induced xerostomia. and propagated contours with the maximum voxel size, the accuracy of the deformable registration and contour propagation in MIM software was validated. REFERENCES B. Clinical and dosimetric parameters that can predict parotid shrinkage [1] J. (MIM software I. . Piper, “Deformable Image Registration and A large, positive and significant correlation was found Quality Assurance,” 2015. between the initial parotid gland volume and the volume loss [2] S. Broggi, C. Fiorino, I. Dell’Oca, N. Dinapoli, M. Paiusco, A. after 2-3 months. The same conclusion was also reached in Muraglia, E. Maggiulli, F. Ricchetti, V. Valentini, G. Sanguineti, G. research performed by Broggi et al. (2010) [2]. In the same M. Cattaneo, N. Di Muzio, and R. Calandrino, “A two-variable study other parameters predicting the parotid shrinkage in linear model of parotid shrinkage during IMRT for head and neck acute phase are: mean planned dose to parotid gland and age. cancer,” Radiother. Oncol., vol. 94, no. 2, pp. 206–212, 2010. In this thesis however, no correlation between age and relative volume loss in acute phase is found. In terms of planned mean dose to the parotid glands, there seems to be no correlation with the acute phase relative volume loss and a positive correlation with the late phase relative volume loss. Correlation between mean dose and absolute volume loss, gives the same conclusion. It was also found that there was a significant difference between the planned mean doses in the 2 subpopulations; this could be one of the reasons for the existence of the 2 subpopulations as the correlation of group 2 (higher mean planned dose) with the relative late phase volume loss is larger than the correlation with group 1. It was found that gender and subpopulation are independent from each other. From the data it was also concluded that there was a significant difference in age between the man (64,9 years) and woman (46,6 years); the women are younger than the man. Furthermore, parotid glands of female patients seem to be more ‘rigid’: there is less initial volume loss, but also less recovery later on. However, no significant differences are found between volume losses in man vs. women. C. Reduction in contouring time The use of the contour propagation tool will reduce the time needed for contouring with about 50%. This saves a lot of time, which can be an important factor in clinical practice. Table of contents PERMISSION FOR USAGE I PREFACE II ABSTRACT III EXTENDED ABSTRACT IV TABLE OF CONTENTS VII LIST OF FIGURES X LIST OF TABLES XII LIST OF ABBREVIATIONS XIII CHAPTER 1 1 INTRODUCTION 1 1 BACKGROUND 1 2 GOAL OF THIS THESIS 2 3 OUTLINE OF THIS THESIS 2 CHAPTER 2 4 LITERATURE STUDY 4 1 ONCOLOGY 4 1.1 Oncology: facts and figures 4 1.2 Tumour development and progression 5 1.3 Prevention and treatment of cancers 6 1.3.1 Types of treatment therapies 7 1.4 Cancers of the head and neck region 9 1.4.1 Head and neck cancer 9 1.4.2 Treatment of HNC 10 2 RADIATION ONCOLOGY 12 2.1 Ionizing radiation 12 2.2 Interactions with matter 13 2.3 The use of radiation therapy in clinical practice 18 2.3.1 Internal radiation therapy 18 2.3.2 External beam therapy 18 vii 2.4 Side-‐effects of radiation therapy 25 2.4.1 Stochastic effects vs. tissue reactions 25 2.4.2 Early vs. late responding tissues 25 2.4.3 Effects in HNC 26 3 IMAGING TECHNIQUES 29 3.1 Overview and incentive 29 3.1.1 X-‐ray imaging and CT 29 3.1.2 PET and SPECT 30 3.1.3 Ultrasound 31 3.2 MRI 31 3.2.1 Principle 32 3.2.2 Use in radiotherapy 35 3.3 Image analysis in radiotherapy 36 3.3.1 Registration 36 3.3.2 Contour propagation 39 CHAPTER 3 41 SOFTWARE FOR REGISTRATION 41 1 USER-‐DEPENDENT SOFTWARE 42 2 COMMERCIAL SOFTWARE 43 2.1 About MIM 43 2.2 Registration Algorithms in MIM 43 2.2.1 Rigid Registration 44 2.2.2 Deformable registration 46 2.2.3 Contour propagation 49 2.3 Evaluation tools in MIM 49 2.3.1 Evaluation tools for registration 49 2.3.2 Evaluation tools for contour propagation 50 CHAPTER 4 53 EXPERIMENTAL RESEARCH 53 1 INTRODUCTION 53 2 PATIENT-‐DATABASE 54 3 MIM SOFTWARE 56 3.1 Determination of useful parameters 56 3.1.1 Patient subset 56 3.1.2 Rigid Registration 57 3.1.3 Deformable registration 59 3.1.4 Conclusions 67 3.2 Validation of parameter setting 68 viii
Description: